Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|8|1466-1487

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.8, 2013-03, pp. : 1466-1487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human papillomavirus (HPV) vaccine prevents cervical precancers and noninvasive cervical cancers

By  

Inpharma, Vol. 1, Iss. 1509, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Emerging human papillomavirus vaccines

By Christensen Neil D  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 5-19

Informa Healthcare

Access to resources Recommend Favorite

Emerging human papillomavirus vaccines

By Ma Barbara  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. : 469-492

Informa Healthcare

Access to resources Recommend Favorite

Identification of High-risk Human Papillomavirus (hrHPV)-associated Genes in Early Stage Cervical Squamous Cell Carcinomas

By Hu Y   Liu Y   Liu C-B   Ling Z-Q  

The Journal of International Medical Research, Vol. 39, Iss. 3, 2011-05 ,pp. : 712-728

Field House Publishing

Access to resources Recommend Favorite

Recent developments in human papillomavirus vaccines

By Stern Peter L  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 959-971

Informa Healthcare

Access to resources Recommend Favorite